Brief: Global Medical REIT Q2 FFO USD 14.262 Million

Chiron Real Estate

05/08/2025 21:07

Overview

Global Medical REIT Q2 rental revenue up 10.7% yr/yr due to acquisitions

Company completes $69.6 mln acquisition of five-property medical portfolio

Co reaffirms full year 2025 AFFO guidance

Outlook

Company reaffirms full-year 2025 AFFO guidance of $0.89 to $0.93 per share

Company expects to complete refinancing of $350 mln Term Loan A by Q4 2025

Result Drivers

ACQUISITIONS - Rental revenue increased 10.7% yr/yr primarily due to acquisitions completed after June 2024

LEASE OCCUPANCY - Full occupancy of Beaumont, TX facility by CHRISTUS Health contributed to revenue

EXPENSE INCREASE - Higher G&A costs linked to CEO succession plan and acquisition-related expenses

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Rental Revenue
$37.88 mln
Q2 Net Income
$585,000
Q2 Adjusted FFO
$16.60 mln
Q2 FFO
$14.26 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the specialized reits peer group is "buy"

Wall Street's median 12-month price target for Global Medical REIT Inc is $8.75, about 23.5% above its August 4 closing price of $6.69

The stock recently traded at 51 times the next 12-month earnings vs. a P/E of 105 three months ago

Press Release: ID:nBw1D2mmla

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)